Annual Retained Earnings
-$222.80 M
-$52.37 M-30.73%
December 31, 2023
Summary
- As of February 7, 2025, ABOS annual retained earnings is -$222.80 million, with the most recent change of -$52.37 million (-30.73%) on December 31, 2023.
- During the last 3 years, ABOS annual retained earnings has fallen by -$195.83 million (-726.25%).
- ABOS annual retained earnings is now -1034.41% below its all-time high of -$19.64 million, reached on December 31, 2019.
Performance
ABOS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$287.97 M
-$29.77 M-11.53%
September 30, 2024
Summary
- As of February 7, 2025, ABOS quarterly retained earnings is -$287.97 million, with the most recent change of -$29.77 million (-11.53%) on September 30, 2024.
- Over the past year, ABOS quarterly retained earnings has dropped by -$81.67 million (-39.59%).
- ABOS quarterly retained earnings is now -967.95% below its all-time high of -$26.96 million, reached on December 1, 2020.
Performance
ABOS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ABOS Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.7% | -39.6% |
| 3 y3 years | -726.3% | -48.9% |
| 5 y5 years | -1034.4% | -48.9% |
ABOS Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -74.7% | at low | -125.7% | at low |
| 5 y | 5-year | -1034.4% | at low | -968.0% | at low |
| alltime | all time | -1034.4% | at low | -968.0% | at low |
Acumen Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$287.97 M(+11.5%) |
| Jun 2024 | - | -$258.21 M(+8.6%) |
| Mar 2024 | - | -$237.67 M(+6.7%) |
| Dec 2023 | -$222.80 M(+30.7%) | -$222.80 M(+8.0%) |
| Sep 2023 | - | -$206.30 M(+6.7%) |
| Jun 2023 | - | -$193.34 M(+6.4%) |
| Mar 2023 | - | -$181.73 M(+6.6%) |
| Dec 2022 | -$170.43 M | -$170.43 M(+8.2%) |
| Sep 2022 | - | -$157.56 M(+7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -$146.85 M(+7.4%) |
| Mar 2022 | - | -$136.70 M(+7.2%) |
| Dec 2021 | -$127.57 M(+373.1%) | -$127.57 M(+7.0%) |
| Sep 2021 | - | -$119.22 M(+3.4%) |
| Jun 2021 | - | -$115.32 M(+113.7%) |
| Mar 2021 | - | -$53.96 M(+100.1%) |
| Dec 2020 | -$26.96 M(+37.3%) | - |
| Dec 2020 | - | -$26.96 M |
| Dec 2019 | -$19.64 M | - |
FAQ
- What is Acumen Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals annual retained earnings year-on-year change?
- What is Acumen Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals quarterly retained earnings year-on-year change?
What is Acumen Pharmaceuticals annual retained earnings?
The current annual retained earnings of ABOS is -$222.80 M
What is the all time high annual retained earnings for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high annual retained earnings is -$19.64 M
What is Acumen Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, ABOS annual retained earnings has changed by -$52.37 M (-30.73%)
What is Acumen Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of ABOS is -$287.97 M
What is the all time high quarterly retained earnings for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high quarterly retained earnings is -$26.96 M
What is Acumen Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, ABOS quarterly retained earnings has changed by -$81.67 M (-39.59%)